Hashimoto thyroiditis, anti-thyroid antibodies and systemic lupus erythematosus.

There is a two-fold increased risk of HT in SLE patients. Anti-Sm antibodies favor this association and also double antibody positivity. Disease activity and cumulative damage are not related to HT or with autoantibodies.